Renaissance Technologies (RenTech)'s OKYO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 11,200 shares of OKYO Pharma Limited (OKYO) worth $16,800, representing 0.00% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in OKYO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 96,800 shares. Largest reduction occurred in Q1 2026, reducing 138,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s OKYO Pharma Limited (OKYO) Holding Value Over Time
Track share changes against reported price movement
Quarterly OKYO Pharma Limited (OKYO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +11,200 | New Buy | 11,200 | $1.50 |
| Q1 2026 | -138,000 | Sold Out | 0 | $0.00 |
| Q4 2025 | +96,800 | Add 234.95% | 138,000 | $2.07 |
| Q3 2025 | +41,200 | New Buy | 41,200 | $2.00 |
| Q2 2025 | -13,946 | Sold Out | 0 | $0.00 |
| Q1 2025 | -2,554 | Reduce 15.48% | 13,946 | $1.27 |
| Q4 2024 | +16,500 | New Buy | 16,500 | $1.15 |
| Q1 2024 | -11,800 | Sold Out | 0 | $0.00 |
| Q4 2023 | -4,547 | Reduce 27.82% | 11,800 | $1.78 |
| Q3 2023 | +16,347 | New Buy | 16,347 | $1.84 |
Renaissance Technologies (RenTech)'s OKYO Pharma Limited Investment FAQs
Renaissance Technologies (RenTech) first purchased OKYO Pharma Limited (OKYO) in Q3 2023, acquiring 16,347 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held OKYO Pharma Limited (OKYO) for 10 quarters since Q3 2023.
Renaissance Technologies (RenTech)'s largest addition to OKYO Pharma Limited (OKYO) was in Q4 2025, adding 138,000 shares worth $285,660.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 11,200 shares of OKYO Pharma Limited (OKYO), valued at approximately $16,800.
As of the Q2 2026 filing, OKYO Pharma Limited (OKYO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in OKYO Pharma Limited (OKYO) was 138,000 shares, as reported at the end of Q4 2025.